CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

The Changing Role of CIO in the Biopharmaceutical Industry

Andy Newsom, CIO, CSL Behring
Tweet

“It is not the strongest of the species that survive, nor the most intelligent, but the most responsive to change,” Charles Darwin observed in explaining his theory of evolution.


Today the role of the CIO is rapidly evolving, especially in the biopharmaceutical industry, and  CIOs must recognize and adapt to these changes.  The CIO’s role has shifted from technologist to business partner and change agent.  This is mainly driven by technology advancements and their adoption by the business, the pace at  which the industry is changing, and increasing competition.  For the foreseeable future this shift is expected to continue, thus it is important to understand how these factors impact the role of the CIO and IT as a whole for the biopharmaceutical industry. 


The New Age CIO must make the shift from technologist to business partner.  It’s no longer just about delivering technology but understanding the business process and delivering business solutions.   As the leader of IT, the CIO needs to ensure that the IT organization is led by business  rather than driven by technology.  This can be done through organization design, processes and governance.  The CIO and the IT leadership must be more active in connecting to the business, ensuring that the IT strategy is tightly aligned to the business strategy.  This shift from technologist to business partner will ensure the proper IT focus and result in delivering the greatest business value.


Unlike other industries which have shown flat to modest business growth, the biopharmaceutical industry has had strong growth in the past 10 years, often in double digits.   This has resulted in the willingness by the business to invest in IT, providing they are getting business value.  The CIO still needs to be a good steward of the company operational expenses, but at the same time, show where the proper investments can contribute to the required business growth.  Unlike IT organizations of the past where IT was viewed as a utility that didn’t provide much value, today most businesses view IT as a required strategic partner to support their strategic goals.It is clear to see that today’s CIO must deliver systems and services that contribute to the business objectives.


Almost all biopharmaceutical companies are global and therefore under pressure from  many regulatory agencies.  These regulations, which are constantly changing, include not just quality regulations such as those mandated by the U.S. Food and Drug Administration, Australia’s Therapeutic Goods Administration, and the European Medicines Agency, but also financial regulations such as Sarbanes–Oxley and IT general controls.  In addition to compliance with quality and financial regulations, IT organizations also must comply with legal regulations such as data privacy laws.


CIOs must be familiar with these changing regulations to ensure they have the proper governance in place to manage regulatory risks. It is important that today’s biopharmaceutical CIO is driving the proper quality culture and ensuring that solid IT quality management systems are in place.


The biopharmaceutical industry is becoming increasingly competitive as more companies are joining an already crowded industry. This is driving growth in the industry at an accelerated pace. The challenge for the CIO is in keeping pace with business to ensure company success and not hinder business growth. Further, today’s CIO is tasked with managing the balance between performance and control. As more controls are introduced, IT performance can be negatively impacted, resulting in less efficient processes. The key to balancing and keeping pace with the business is to ensure IT has the right people, process, and technology in place.


As IT leaders, CIO needs to ensure that the IT organization is led by business, and not driven by technology


It is also important to understand what has not changed substantially in the role of the CIO in the biopharmaceutical industry. Talent management has always been a key role of the CIO. It is critical to the success of any IT organization to find, develop, and retain good IT talent. Since the 1990s, technology has been a strategic driver for most all industries and not just the biopharmaceutical industry. As a result, more pressure has been put on companies to find and retain key IT skills and leadership. This trend is not expected to change, so it is important that talent management be a key foundational component of the CIO strategy. An organization is only as successful as the people who run it.


As Charles Darwin said, it is the species that is most responsive to change that survives. This is applicable to the role of the CIO in the biopharmaceutical industry. The biopharmaceutical business will continue to be a fast paced, rapidly growing industry that will rely heavily on evolving technologies such as social, mobile, analytics and cloud to support their competiveness in the crowded space. The ever changing regulatory environment will continue to be a challenge for almost every CIO in the biopharmaceutical industry. CIOs will need to be business partners and change agents that understand the business and are aligned with the business strategy. This will ensure IT is providing the highest value at the speed required by the business.


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Three Steps To Succeed With Digital Transformation In Pharma?

Philippe Caby, CIO, Centrient Pharmaceuticals
Three Steps To Succeed With Digital Transformation In Pharma?

A Tale of Transformational Leadership in the IT&S Setting

Pam Banchy, CIO, VP Clinical Informatics, Western Reserve Hospital/Western Reserve Health System
A Tale of Transformational Leadership in the IT&S Setting

The CIO's Spice Rack

Praseed Thapparambil, CIO, National Assoc. of Boards of Pharmacy
The CIO's Spice Rack

Technology Enables Patient Empowerment

Technology Enables Patient Empowerment
Aligning IT with the Cadence of your Business

Aligning IT with the Cadence of your Business

William Leonard, ScD, Chief Information Officer, MPI Research
Data Governance is Relatively New to the Healthcare Industry

Data Governance is Relatively New to the Healthcare Industry

William Phillips,SVP & CIO,University Health System

DNA Infusion-Providing an Identity and Voice to Pharmaceuticals

Judy Murrah, CIO, Applied DNA Sciences Inc
DNA Infusion-Providing an Identity and Voice to Pharmaceuticals

Beyond the Pill, IT Leads the Technology Revolution at Teva Pharmaceuticals

Guy Hadari, VP & CIO, Teva Pharmaceuticals
Beyond the Pill, IT Leads the Technology Revolution at Teva Pharmaceuticals
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cioviewpoint/the-changing-role-of-cio-in-the-biopharmaceutical-industry-nwid-21.html